NIFEDIPINE | A072409 | CHASE LABORATORIES INC
Total Spending
$786K
Total Claims
13,676
Beneficiaries
4,898
Avg Cost/Unit
$0.63
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
8 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
No patent or exclusivity listings for this strength.